How technological innovation affects the structure of an industry: entrepreneurship evolution in the biotechnology and pharmaceutical industry since 1980

ABSTRACT Challenges faced by the biotechnology and pharmaceutical industry, including reduced R&D productivity and the expiration of drugs that are high in demand, are recently being addressed through technological innovation. Such innovations are highly likely to change the structure and functioning of the industry. Since 2000, biotechnology and pharmaceutical companies have actively made strategic alliance, and technological innovations have changed the source of innovation from R&D to entrepreneurship within the industry. In this study, we identify the evolution of entrepreneurship and discuss the changes caused by technological advancements since 1980 by analysing patterns of exporting and acquiring technology data from Medtrack. Over difference period, biopharmaceutical firms have gained new knowledge and improved technology, and have implemented this newly acquired knowledge and innovation to introduce drugs to the market.

[1]  Henry Chesbrough,et al.  Open Innovation: The New Imperative for Creating and Profiting from Technology , 2003 .

[2]  S. Venkataraman.  Chapter 1 The Distinctive Domain of Entrepreneurship Research , 2019, Advances in Entrepreneurship, Firm Emergence and Growth.

[3]  J. Brown,et al.  Bridging epistemologies: The generative dance between organizational knowledge and organizational knowing , 1999, STUDI ORGANIZZATIVI.

[4]  I. Cockburn,et al.  Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research. , 2001, Journal of health economics.

[5]  S. Shane.  A General Theory of Entrepreneurship: The Individual-Opportunity Nexus , 2003 .

[6]  J. Schumpeter.  The Theory of Economic Development: An Inquiry into Profits, Capital, Credit, Interest, and the Business Cycle , 1934 .

[7]  James W. Carland,et al.  Differentiating Entrepreneurs from Small Business Owners: A Conceptualization , 1984 .

[8]  J. Tidd,et al.  Innovation and Entrepreneurship , 2007 .

[9]  David Carson.  Marketing and entrepreneurship in SMEs : an innovative approach , 1995 .

[10]  Martin Kenney,et al.  Schumpeterian innovation and entrepreneurs in capitalism: A case study of the U.S. biotechnology industry , 1986 .

[11]  John Seely Brown,et al.  Book Reviews : The Social Life of Information By John Seely Brown and Paul Duguid. Boston: Harvard Business School Press, 2000. 320 pages , 2000 .

[12]  Nadine Roijakkers,et al.  Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks , 2006 .

[13]  R. Henderson.  The evolution of integrative capability: innovation in cardiovascular drug discovery , 1994 .

[14]  R. Laforge,et al.  Research at the Marketing Interface to Advance Entrepreneurship Theory , 1992 .

[15]  Paul Hibbert.  Inter-organizational collaboration , 2010 .

[16]  V. Chiesa,et al.  Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis , 2011 .

[17]  James W. Carland,et al.  A proclivity for entrepreneurship: A comparison of entrepreneurs, small business owners, and corporate managers , 1999 .

[18]  A. Arora,et al.  COMPLEMENTARITY AND EXTERNAL LINKAGES: THE STRATEGIES OF THE LARGE FIRMS IN BIOTECHNOLOGY* , 1990 .

[19]  John Scott.  Social Network Analysis , 1988 .

[20]  John Bessant,et al.  Managing Innovation: Integrating Technological, Market, and Organizational Change, 2nd Edition , 2001 .

[21]  W. Powell,et al.  Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .

[22]  J. Schumpeter.  Capitalism, Socialism and Democracy , 1943 .